UBS Group AG
- SEC CIK
- 0001610520
- Latest filing
- Aug 13, 2026
KAPA holding history
Kairos Pharma, LTD. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
KAPA overviewAll 13F holders of KAPAFull Q2 2026 holdings
- Shares (Q2 2026)
- 6,261
- Value
- $2.40K
- % of portfolio
- <0.1%
- Quarters held
- 5
- Since Q4 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 6,261 | $2.40K | <0.1% | +6,261 | New | Holders |
| Q4 2025 | 0 | $0 | 0.0% | −5,979−100.0% | Sold out | Holders |
| Q3 2025 | 5,979 | $7.00K | <0.1% | −3,479−36.8% | Reduced | Holders |
| Q2 2025 | 9,458 | $6.71K | <0.1% | +6,666+238.8% | Added | Holders |
| Q1 2025 | 2,792 | $2.61K | <0.1% | −8,053−74.3% | Reduced | Holders |
| Q4 2024 | 10,845 | $16.5K | <0.1% | +10,845 | New | Holders |